Sign in

CIK 0001598646

  • Non-accelerated filer
  • Smaller reporting company

Minerva Neurosciences, Inc.

Sign in to watch
Ticker
NERV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
260784194
Phone
+1 617-600-7373
Business address
1500 DISTRICT AVENUE, BURLINGTON, MA, 01803
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 29 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-12-13 Davidson Michael Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +125,000 125,000
2017-12-13 Saoud Jay SVP and Head of R&D Grant or award · Employee Stock Option (Right to Buy) +175,000 175,000
2017-12-13 Race Geoff EVP, CFO & CBO Grant or award · Employee Stock Option (Right to Buy) +200,000 200,000
2017-12-11 Russell Richard E. President Grant or award +40,000 40,000
2017-12-11 Russell Richard E. President Grant or award · Employee Stock option (Right to Buy) +775,000 775,000
2017-12-10 HASLER HANS PETER Director Grant or award · Option Grant (Right to Buy) +40,000 40,000
2017-12-10 DOYLE WILLIAM F Director Grant or award · Option Grant (Right to Buy) +40,000 40,000
2017-09-01 Saoud Jay SVP and Head of R&D Grant or award · Employee Stock Option (Right to Buy) +100,000 100,000
2017-08-29 JOHNSON & JOHNSON 10% owner Other disposition −3,892,256 $0.00 $389 0
2017-07-24 Vandervelpen Nico Director Returned to the company · Stock Option (Right to Buy) −25,000 0
2017-07-24 Vandervelpen Nico Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2017-07-24 Vandervelpen Nico Director Returned to the company · Stock Option (Right to Buy) −12,500 0
2017-07-24 Vandervelpen Nico Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2017-07-24 Vandervelpen Nico Director Returned to the company · Stock Option (Right to Buy) −12,500 0
2017-07-24 Vandervelpen Nico Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2017-06-01 VAN HEEK G JAN Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2017-06-01 Ahlholm Frederick W SVP, Chief Accounting Officer Option exercise +14,381 $5.19 $75K 19,381
2017-06-01 Ahlholm Frederick W SVP, Chief Accounting Officer Option exercise +7,250 $4.71 $34K 26,631
2017-06-01 Ahlholm Frederick W SVP, Chief Accounting Officer Sale −11,250 $10.00 $113K 15,381
2017-06-01 Ahlholm Frederick W SVP, Chief Accounting Officer Sale −10,381 $11.00 $114K 5,000

Page 12 of 16 · 305 trades